
News from Globes
Media Bias Ratings
Average Bias Rating:
Center
Center
byMedia Bias/Fact CheckDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Globes News

Stock Markets · IsraelTeva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported its fourth-quarter 2025 financial results on Wednesday, with total revenue of $4.71 billion, beating analysts' expectations of $4.37 billion, according to Benzinga Pro. Revenues increased 11% year-over-year in U.S. dollars or 9% in local currency. The increase was mainly due to development milestone payments received in connection with the initiation of Phase 3 studies for duvakitug (anti…See the Story
Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook - Teva Pharmaceutical Indus (NYSE:TEVA)
50% Left coverage: 8 sources

